These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16881851)

  • 1. Effect of mitotane on pituitary corticotrophs in clinically normal dogs.
    Taoda T; Hara Y; Takekoshi S; Itoh J; Teramoto A; Osamura RY; Tagawa M
    Am J Vet Res; 2006 Aug; 67(8):1385-94. PubMed ID: 16881851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis.
    Teshima T; Hara Y; Takekoshi S; Nezu Y; Harada Y; Yogo T; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):32-44. PubMed ID: 19041802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo correlation between c-Fos expression and corticotroph stimulation by adrenocorticotrophic hormone secretagogues in rat anterior pituitary gland.
    Takigami S; Fujiwara K; Kikuchi M; Yashiro T
    Cell Tissue Res; 2008 Mar; 331(3):589-94. PubMed ID: 18092182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function.
    Gentilin E; Tagliati F; Terzolo M; Zoli M; Lapparelli M; Minoia M; Ambrosio MR; Degli Uberti EC; Zatelli MC
    J Endocrinol; 2013 Sep; 218(3):275-85. PubMed ID: 23814013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of urine cortisol:creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs.
    Angles JM; Feldman EC; Nelson RW; Feldman MS
    J Am Vet Med Assoc; 1997 Oct; 211(8):1002-4. PubMed ID: 9343543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.
    Pecori Giraldi F; Bucciarelli LG; Saccani A; Scacchi M; Pesce S; Losa M; Cavagnini F
    J Neuroendocrinol; 2007 Mar; 19(3):208-12. PubMed ID: 17280594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal steroid hormone concentrations in dogs with hair cycle arrest (Alopecia X) before and during treatment with melatonin and mitotane.
    Frank LA; Hnilica KA; Oliver JW
    Vet Dermatol; 2004 Oct; 15(5):278-84. PubMed ID: 15500479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year follow-up evaluation of magnetic resonance imaging of the brain in dogs with pituitary-dependent hyperadrenocorticism.
    Bertoy EH; Feldman EC; Nelson RW; Dublin AB; Reid MH; Feldman MS
    J Am Vet Med Assoc; 1996 Apr; 208(8):1268-73. PubMed ID: 8635969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of corticotrophin-releasing hormone on corticotrophs in anterior pituitary gland allografts in hypophysectomized, orchidectomized hamsters.
    Horacek MJ; Campbell GT; Blake CA
    Cell Tissue Res; 1989 Oct; 258(1):65-8. PubMed ID: 2553264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of the androgen receptor in the diencephalon and the pituitary gland in goats: Co-localisation with corticotrophin releasing hormone, arginine vasopressin and corticotrophs.
    Maejima Y; Aoyama M; Ookawara S; Hirao A; Sugita S
    Vet J; 2009 Aug; 181(2):193-9. PubMed ID: 18474445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog.
    Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM
    J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo temporal aspects of ACTH secretion: stimulatory actions of corticotropin-releasing hormone and vasopressin in cattle.
    Carroll JA; McArthur NH; Welsh TH
    J Vet Med A Physiol Pathol Clin Med; 2007 Feb; 54(1):7-14. PubMed ID: 17359448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral administration of controlled-ileal-release budesonide and assessment of pituitary-adrenocortical axis suppression in clinically normal dogs.
    Stroup ST; Behrend EN; Kemppainen RJ; Smith-Carr S
    Am J Vet Res; 2006 Jul; 67(7):1173-8. PubMed ID: 16817739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-Tyr0-hCRH labelling characteristics of corticotropin-releasing hormone receptors: differences between normal and adenomatous corticotrophs.
    Abs R; Smets G; Vauquelin G; Verhelst J; Mahler C; Verlooy J; Stevenaert A; Wouters L; Borgers M; Beckers A
    Neurochem Int; 1997 Mar; 30(3):291-7. PubMed ID: 9041560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of melanotroph- and corticotroph-type proopiomelanocortin derivatives into blood after administration of corticotropin-releasing hormone in patients with septic shock without adrenocortical insufficiency.
    Matejec R; Löcke G; Mühling J; Harbach HW; Langefeld TW; Bödeker RH; Hempelmann G
    Shock; 2009 Jun; 31(6):553-60. PubMed ID: 18827746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-specific effects of perinatal glucocorticoid treatment on anterior pituitary morphology, annexin 1 expression and adrenocorticotrophic hormone secretion in the adult female rat.
    John CD; Theogaraj E; Christian HC; Morris JF; Smith SF; Buckingham JC
    J Neuroendocrinol; 2006 Dec; 18(12):949-59. PubMed ID: 17076770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the urine cortisol: creatinine ratio to monitor treatment response in dogs with pituitary-dependent hyperadrenocorticism.
    Guptill L; Scott-Moncrieff JC; Bottoms G; Glickman L; Johnson M; Glickman N; Nelson R; Bertoy E
    J Am Vet Med Assoc; 1997 Apr; 210(8):1158-61. PubMed ID: 9108922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of mitotane therapy in dogs with pituitary dependent Cushing syndrome on the adrenal gland size--an ultrasonographic study].
    Hörauf A; Reusch C
    Schweiz Arch Tierheilkd; 1999; 141(5):239-45. PubMed ID: 10354742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of corticotropin-releasing hormone as a thyrotropin-releasing factor in non-mammalian vertebrates.
    De Groef B; Van der Geyten S; Darras VM; Kühn ER
    Gen Comp Endocrinol; 2006 Mar; 146(1):62-8. PubMed ID: 16337947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.